In the present study, we chose three representative tumor cells (HepG2, HeLa, and MCF-7 cells) for all tests that exhibited high, moderate and low sensitivity to CA-4, respectively, according to preliminary findings (S1 Fig). This evidence concerns the gene CA4 and neoplasm.